Latest Health News
Nxera Pharmas QUVIVIQ (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with…
Transactions in connection with share buy-back program
Company announcement no. 10 - 2614 April 2026 Transactions in connection with…
Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative personalized off-the-shelf immunotherapy toward clinical development
April 14, 2026 03:30 ET | Source: Asgard Therapeutics Medical oncologist (ex…
EmPRO Reports Another Year of Strong Financial Results with Significant Growth in Net Income and Surplus During 2025
ROSLYN, N.Y., April 13, 2026 (GLOBE NEWSWIRE) -- EmPRO Insurance Company (EmPRO),…
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
April 13, 2026 09:00 ET | Source: Senti Biosciences, Inc. SOUTH SAN…
Switchback Medical Signs Lease for 18,000 Square Foot Facility in Costa Ricas Coyol Free Trade Zone
BROOKLYN PARK, MN, April 13, 2026 (GLOBE NEWSWIRE) -- Switchback Medical, a…
Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas
Join the Grand Opening Celebration on May 1, 2026, for an Evening…
Pelthos Therapeutics Announces CFO Transition
Senior Vice President, Finance & Accounting John M. Gay named Chief Financial…
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy – CORRECTION
April 10, 2026 16:09 ET | Source: Mesoblast Limited Working with Parent…
